beta blocker

What Is a Beta Blocker?

A beta blocker is a class of medication that blocks the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) at beta-adrenergic receptors in the body. Commonly prescribed for cardiovascular conditions such as high blood pressure, arrhythmias, angina, and certain heart conditions, beta blockers are also sometimes prescribed for anxiety and performance-related stress.

Beta Blockers and Polygraph Testing

Beta blockers are of particular concern in polygraph testing because they specifically dampen cardiovascular phasic responsiveness — reducing heart rate reactivity, blunting blood pressure responses, and attenuating pulse amplitude changes. These are precisely the physiological features that examiners evaluate in the cardiograph channel.

Are Beta Blockers an Effective Countermeasure?

While beta blockers have been discussed as a potential pharmacological countermeasure, testing examinees who take beta blockers is routine practice in the polygraph field. Research and clinical experience indicate that some cardiovascular responsiveness typically persists even with the medication, because the polygraph evaluates differential responding between question types rather than absolute response levels. If a beta blocker reduces all cardiovascular responses by a similar proportion, the relative differences between relevant and comparison question responses remain detectable.

Moreover, the polygraph records multiple physiological channels. Even if cardiovascular responses are attenuated, the electrodermal and respiratory channels — which operate through different neurochemical pathways (cholinergic rather than adrenergic) — are not directly affected by beta blockers.

Examiner Considerations

During the pre-test interview, examiners routinely ask about all medications, including beta blockers. This information allows the examiner to adjust interpretive weight across channels — placing greater emphasis on electrodermal and respiratory data when cardiovascular responses may be pharmacologically attenuated. Honest disclosure of medication use supports the most accurate assessment possible.